Las Heras Macarena, Szenfeld Benjamín, Ballout Rami A, Buratti Emanuele, Zanlungo Silvana, Dardis Andrea, Klein Andrés D
Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, 7780272, Chile.
Department of Pediatrics, University of Texas Southwestern (UTSW) Medical Center and Children's Health, Dallas, TX, 75235, USA.
NPJ Genom Med. 2023 Aug 11;8(1):21. doi: 10.1038/s41525-023-00365-w.
Niemann-Pick type C (NPC) disease is a lysosomal storage disease (LSD) characterized by the buildup of endo-lysosomal cholesterol and glycosphingolipids due to loss of function mutations in the NPC1 and NPC2 genes. NPC patients can present with a broad phenotypic spectrum, with differences at the age of onset, rate of progression, severity, organs involved, effects on the central nervous system, and even response to pharmacological treatments. This article reviews the phenotypic variation of NPC and discusses its possible causes, such as the remaining function of the defective protein, modifier genes, sex, environmental cues, and splicing factors, among others. We propose that these factors should be considered when designing or repurposing treatments for this disease. Despite its seeming complexity, this proposition is not far-fetched, considering the expanding interest in precision medicine and easier access to multi-omics technologies.
尼曼-匹克C型(NPC)病是一种溶酶体贮积病(LSD),其特征是由于NPC1和NPC2基因的功能丧失突变,导致内溶酶体胆固醇和糖鞘脂蓄积。NPC患者可表现出广泛的表型谱,在发病年龄、进展速度、严重程度、受累器官、对中枢神经系统的影响以及对药物治疗的反应等方面存在差异。本文综述了NPC的表型变异,并讨论了其可能的原因,如缺陷蛋白的残余功能、修饰基因、性别、环境线索和剪接因子等。我们建议,在设计或重新利用该疾病的治疗方法时应考虑这些因素。尽管其看似复杂,但考虑到对精准医学的兴趣不断扩大以及多组学技术的获取更加容易,这一主张并非牵强附会。